Loading…
State Opioid Response Grant Authorization Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
88pct
196d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
State Opioid Response Grant Authorization Act of 2021 This bill reauthorizes through FY2027 and otherwise changes the State Opioid Response Grant program. This program, which is managed by the Substance Abuse and Mental Health Services Administration, provides funding for states, territories, and Indian tribes and tribal organizations to address the opioid crisis. Specific changes to the program include (1) expanding its scope to also address stimulant use and misuse, (2) establishing a funding methodology and minimum funding allocations, and (3) allowing the use of grant funds for recovery support services. The bill also requires the Government Accountability Office to report on issues concerning the funding and other aspects of the program.
Yes
380
No
46
Present
0
Not Voting
5
Party Breakdown
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (15)
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 380 - 46 (Roll no. 320). (text: CR 10/19/2021 H5647-5648)
HousePassed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 380 - 46 (Roll no. 320).(text: CR 10/19/2021 H5647-5648)
HouseConsidered as unfinished business. (consideration: CR H5699-5700)
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
DEBATE - The House proceeded with forty minutes of debate on H.R. 2379.
Considered under suspension of the rules. (consideration: CR H5647-5650)
Bills with similar content found using semantic analysis.
Sources: Congress.gov · House Clerk roll-call votes
| house |
| On Motion to Suspend the Rules and Pass, as Amended |
Passed |
| October 20, 2021 |
2023 · third_quarter · Budget/Appropriations
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987/H.R. 4341 - Comprehensive Addiction and Recovery Act (CARA) 3.0 (117th Congress); H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 (117th Congress); H.R 2366/S.1457 - Stop Fentanyl Act (117th Congress); H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 (117th Congress); Issues related to the development, manufacture, and distribution of coronavirus vaccines; FY23 Omnibus appropriations bill (PL 117-328) and FY24 appropriations bills; Further Extending Government Funding Act (PL 117-70); Appropriations funding for FY23 related to medical countermeasures and opioid overdose; Issues regarding funding of the Strategic National Stockpile.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2023 · second_quarter · Budget/Appropriations
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987/H.R. 4341 - Comprehensive Addiction and Recovery Act (CARA) 3.0 (117th Congress); H.R. 2379 -State Opioid Response Grant Authorization Act of 2021 (117th Congress); H.R 2366/S.1457 - Stop Fentanyl Act (117th Congress), H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 (117th Congress); Issues related to the development, manufacture, and distribution of coronavirus vaccines; FY23 Omnibus appropriations bill (P.L. 117-328) and FY24 appropriations bills, HR 6119 - Further Extending Government Funding Act; Appropriations funding for FY23 related to medical countermeasures and opioid overdose; Issues regarding funding of the Strategic National Stockpile.
Client expense: Not reported · Firm income: $60,000
2023 · first_quarter · Budget/Appropriations
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987/H.R. 4341 - Comprehensive Addiction and Recovery Act (CARA) 3.0 (117th Congress); H.R. 2379 -State Opioid Response Grant Authorization Act of 2021 (117th Congress); H.R 2366/S.1457 - Stop Fentanyl Act (117th Congress), H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 (117th Congress); Issues related to the development, manufacture, and distribution of coronavirus vaccines; FY23 Omnibus appropriations bill (P.L. 117-328) and FY24 appropriations bills, HR 6119 - Further Extending Government Funding Act; Appropriations funding for FY23 related to medical countermeasures and opioid overdose; Issues regarding funding of the Strategic National Stockpile.
Client expense: Not reported · Firm income: $60,000
2022 · fourth_quarter · Budget/Appropriations
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
2022 · fourth_quarter · Health Issues
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 109.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-149.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Subcommittee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| House |
| Referred to |
| April 8, 2021 |
| April 8, 2021 |
| Republican |
| IN |
| Kelly Armstrong | Republican | ND |
| Lisa Blunt Rochester | Democratic | DE |
| Mikie Sherrill | Democratic | NJ |
| Ted Budd | Republican | NC |
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Disaster Planning/Emergencies
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Defense
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 H.R 2366/S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R. 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Issues related to health care workforce including Healthcare Workforce Resilience Act (H.R. 2255 / S. 1024) and the Provider Training in Palliative Care Act (S. 2890). S. 4260, Palliative Care and Hospice Education & Training Act. and H.R. 8812, the Improving Care and Access to Nurses (ICAN) Act. Issues related to community based palliative care and advanced care illness management. H.R. 9109, The Grief Resilience Investment and Education Fund (GRIEF) Act and issues regarding bereavement care. Issues related to safe opioid disposal and implementing the Support Act (H.R. 2379).
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Alcohol and Drug Abuse
S. 253 Cannabidiol and Marijuana Research H.R. 2067 Controlled Substances Act H.R. 2355 Informed Dispensing of Medications H.R. 2379 Grant Expansion of Opioid Use Disorders H.R. 5657 Accessible Marijuana Research H.R. 8454 Marijuana Impairment Research **Issued lobbied without specific bill number: Implementation of Marijuana Impairment Research
Client expense: Not reported · Firm income: $42,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 2617 - Consolidated Appropriations Act, 2023 (Omnibus) HR 1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Homeland Security
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 2617 - Consolidated Appropriations Act, 2023 (Omnibus) HR 1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Budget/Appropriations
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 2617 - Consolidated Appropriations Act, 2023 (Omnibus) HR 1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Alcohol and Drug Abuse
S. 253 Cannabidiol and Marijuana Research H.R. 2067 Controlled Substances Act H.R. 2355 Informed Dispensing of Medications H.R. 2379 Grant Expansion of Opioid Use Disorders H.R. 5657 Accessible Marijuana Research H.R. 8454 Marijuana Impairment Research **Issued lobbied without specific bill number: Implementation of Marijuana Impairment Research
Client expense: $1,420,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
2022 · fourth_quarter · Budget/Appropriations
Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Disaster Planning/Emergencies
Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Homeland Security
Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Budget/Appropriations
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · fourth_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · fourth_quarter · Health Issues
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
2022 · fourth_quarter · Homeland Security
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · fourth_quarter · Budget/Appropriations
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987/H.R. 4341 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Appropriations funding for FY23 related to medical countermeasures and opioid overdose; Issues regarding funding of the Strategic National Stockpile.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2022 · third_quarter · Alcohol and Drug Abuse
S. 253 Cannabidiol and Marihuana Research H.R. 2067 Controlled Substances Act H.R. 2355 Informed Dispensing of Medications H.R. 2379 Grant Expansion of Opioid Use Disorders H.R. 5657 Accessible Marijuana Research H.R. 8454 Marijuana Impairment Research
Client expense: Not reported · Firm income: $42,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 6833 - House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Budget/Appropriations
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 6833 - House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Homeland Security
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone HR 6833 - House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues regarding healthcare work force shortages. Palliative Care and Hospice Education & Training Act (S. 2460). Issues related to community based palliative care and advanced care illness management. The Grief Resilience Investment and Education Fund (GRIEF) Act (H.R. 9109) and issues regarding bereavement care. The Expanding Access to Palliative Care Act (S. 2565). Issues affecting hospice providers. The extension of sequestration relief provided under H.R.1868, the Medicare Sequester COVID Moratorium Act (H.R. 315) and Protecting Medicare and American Farmers from Sequester Cuts Act (H.R. 610); the Telehealth Modernization Act (S. 368/H.R.1332) and the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act (S. 1512/H.R. 2903) as it relates to use of telehealth in the certification of a beneficiary for the hospice benefit; The Childrens Program of All-inclusive Coordinated Care (ChiPACC) Act of 2021 (H.R. 4952); The Expanding Access to Palliative Care Act (S.2565). The Health Care Workforce Resilience Act (S. 1024/H.R. 2255); The Provider Training in Palliative Care Act (S. 2890); The Palliative Care Training for Providers Act (H.R. 5376); The Consolidated Appropriations Act, 2022 (H.R. 2471) as related to Medicare sequester relief, telehealth flexibilities, and hospice payment reimbursement; care; Issues related to regulatory relief; Issues involving hospice providers and COVID relief; Issues related to coronavirus; Telehealth Extension and Evaluation Act (S. 3593); the Telehealth Extension Act (H.R. 6202). Issues related to healthcare workforce shortages; Issues related to community-based palliative care and advanced care illness management. The Bipartisan Safer Communities Act (S. 2938) and issues concerning bereavement care. Issues related to safe opioid disposal and implementation of the SUPPORT Act (H.R. 2379).
Client expense: $280,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · third_quarter · Defense
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Budget/Appropriations
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Disaster Planning/Emergencies
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Alcohol and Drug Abuse
S. 253 Cannabidiol and Marihuana Research H.R. 2067 Controlled Substances Act H.R. 2355 Informed Dispensing of Medications H.R. 2379 Grant Expansion of Opioid Use Disorders H.R. 5657 Accessible Marijuana Research H.R. 8454 Marijuana Impairment Research
Client expense: $1,380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 H.R 2366/S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R. 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S. 3799 - PREVENT Pandemics Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues related to health care workforce including Healthcare Workforce Resilience Act (H.R. 2255 / S. 1024) and the Provider Training in Palliative Care Act (S. 2890). S. 4260, Palliative Care and Hospice Education & Training Act. and H.R. 8812, the Improving Care and Access to Nurses (ICAN) Act. Issues related to community based palliative care and advanced care illness management. H.R. 9109, The Grief Resilience Investment and Education Fund (GRIEF) Act and issues regarding bereavement care. Issues related to safe opioid disposal and implementing the Support Act (H.R. 2379).
Client expense: $240,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Budget/Appropriations
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 - authorizes grants to entities for opioid response and requires prescriptions of opioid overdose reversal drugs when prescribing opioids; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 8295 - Department of Labor, Health and Human Services, and Education, and related agencies, appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Disaster Planning/Emergencies
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 - authorizes grants to entities for opioid response and requires prescriptions of opioid overdose reversal drugs when prescribing opioids; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 8295 - Department of Labor, Health and Human Services, and Education, and related agencies, appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Homeland Security
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 - authorizes grants to entities for opioid response and requires prescriptions of opioid overdose reversal drugs when prescribing opioids; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 8295 - Department of Labor, Health and Human Services, and Education, and related agencies, appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 - authorizes grants to entities for opioid response and requires prescriptions of opioid overdose reversal drugs when prescribing opioids; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 8295 - Department of Labor, Health and Human Services, and Education, and related agencies, appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2022 · third_quarter · Budget/Appropriations
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987/H.R. 4341 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Appropriations funding for FY23 related to medical countermeasures and opioid overdose.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2022 · third_quarter · Health Issues
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
2022 · third_quarter · Homeland Security
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · third_quarter · Budget/Appropriations
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · third_quarter · Disaster Planning/Emergencies
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2022 · second_quarter · Alcohol and Drug Abuse
S. 253 Cannabidiol and Marihuana Research H.R. 2067 Controlled Substances Act H.R. 2355 Informed Dispensing of Medications H.R. 2379 Grant Expansion of Opioid Use Disorders H.R. 5657 Accessible Marijuana Research
Client expense: $1,620,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Budget/Appropriations
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Defense
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Disaster Planning/Emergencies
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 *No specific Bill number Appropriations funding for fiscal year 2022. *No specific bill number State Opioid Response Grant funding. *No specific Bill number Substance Abuse and Mental Health Block Grant funding. * No specific bill number CARA 3.0. Comprehensive Addiction and Recovery Act. *No specific Bill Number Emergency Support foe Substance Use Disorders Act/Legislation to create emergency grants for states and community based organizations that serve individuals with substance use disorder. *No specific bill number Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. S.4231 ;Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE